Celebrating the Spirit of Innovation
Our Innovation Prize recognizes the challenge and dedication it takes to start a new company by supporting the innovation process and celebrating life-science entrepreneurs.
Boehringer Ingelheim will award one early-stage bioscience organization the Boston Innovation Prize on March 24th2021.
The Innovation Prize
Valued at $75,000, the winner will receive Boehringer Ingelheim’s ‘Golden Ticket’ –a voucher which represents prepaid rent for one reserved bench in LabCentral’sshared laboratory space in Cambridge, MA. for one year. Boehringer Ingelheim receives this ‘Golden Ticket’ as part of its sponsorship of the LabCentralfacility.
Finalists will be notified on March 17thand invited to present their ideas to a panel of judges in a virtual pitch contest on March 24th.
Entry Requirements
•Early-stage innovators and spin-outs that are pursuing life-science therapeutic platform technologies and therapeutics (in any indication, any modality) are invited to participate. Diagnostics, Instrument development, and Health-IT are excluded.
•Companies must not have a major partnership with another large bio-pharmaceutical company.
•Companies must be focused on new target concepts or drug discovery.
How to Apply
Applicants must provide:
1.A one-page summary of their application
2.A non-confidential deck of no more than eight slides which must address unmet medical need, solution, scientific principle, key data supporting the scientific principle, overview of business case
Submit to: susan.davidson@boehringer-ingelheim.com